Wednesday, June 21, 2006

Prophylaxis Strategies for Contrast-Induced Nephropathy (Diabetes Mellitus)


Prophylaxis Strategies for Contrast-Induced Nephropathy
Journal of American Medical Association (subscription), IL - 21 hours ago Evidence Synthesis Important patient-related risk factors for contrast-induced nephropathy include chronic kidney disease, diabetes mellitus, heart failure

Leg pain could signal chronic condition
KTBS, LA - Jun 15, 2006 The exact cause is unknown, but it is more common in obese individuals and patients with diabetes mellitus. Wearing constrictive

Celera sell-off could net $144M
Business Gazette, MD - 15 hours ago use a significant portion of the money to support an international trial of its lead product candidate, an antibody to treat diabetes mellitus and for

A phase II trial of dexamethasone, vitamin D, and carboplatin in
HeartZine, UK - Jun 17, 2006 Toxicity Criteria, version 2.0), 2 patients with thrombosis, 2 patients with inflammatory bowel symptoms, and 2 patients with new-onset diabetes mellitus.

New Study Showed VYTORIN(R) (Ezetimibe/Simvastatin) Significantly
International News Service, Australia - Jun 18, 2006 In a multicenter, double-blind, 24-week trial, 214 patients with type 2 diabetes mellitus treated with thiazolidinediones (rosiglitazone or pioglitazone) for a

Autoimmune Diseases in Asthma
Annals of Internal Medicine - Jun 19, 2006 Measurements: Cases of type 1 diabetes mellitus, vasculitis, immune thrombocytopenic purpura, inflammatory bowel disease, rheumatoid arthritis, and the

Diabetes Mellitus